SCHEMBL18680519

SCHEMBL18680519

CN(C)c1ccc2cc3ccc(=[N+](C)C)cc-3sc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 4/20 0.59
▸ MAPT P10636 4/20 0.59
▸ THRB P10828 3/20 0.59
▸ MAPK1 P28482 3/20 0.59
▸ RECQL P46063 3/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ TDP1 Q9NUW8 3/20 0.59
▸ APAF1 O14727 3/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ MEN1 O00255 2/20 0.59
▸ GSR P00390 2/20 0.59
▸ POLB P06746 2/20 0.59
▸ PKM P14618 2/20 0.59
▸ MAOA P21397 2/20 0.59
▸ PPARG P37231 2/20 0.59
▸ HTT P42858 2/20 0.59
▸ RAD52 P43351 2/20 0.59
▸ BLM P54132 2/20 0.59
▸ CASP6 P55212 2/20 0.59
▸ KMT2A Q03164 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31656268 0.99 MAPT (0.60) APPMAPTTHRBMAPK1RECQL
SCHEMBL15488839 0.80 ESR1 (0.50) APPMAPTTHRBMAPK1RECQL
SCHEMBL18687000 0.78 APP (0.38) APPMAPTTHRBMAPK1RECQL
Methylene Blue Cation SCHEMBL29441543 0.74 APP (1.00) APPMAPTTHRBMAPK1RECQL
Methylene Blue Cation SCHEMBL127316 0.74 APP (1.00) APPMAPTTHRBMAPK1RECQL
SCHEMBL18680525 0.74 TERT (0.38) APPMAPTTHRBMAPK1RECQL
Methylene Blue Cation SCHEMBL4227551 0.73 APP (1.00) APPMAPTTHRBMAPK1RECQL
Methylene Blue Cation SCHEMBL30021960 0.72 APP (0.97) APPMAPTTHRBMAPK1RECQL
Methylene Blue Cation SCHEMBL29357640 0.72 THRB (1.00) APPMAPTTHRBMAPK1RECQL
Methylene Blue Cation SCHEMBL30664737 0.72 THRB (1.00) APPMAPTTHRBMAPK1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327874-A2 3,6-DISUBSTITUTED XANTHYLIUM SALTS WisTa Laboratories Ltd. (SG) 2024-02-28 — — EP disclosed
EP-3689346-B1 3,6-DISUBSTITUTED XANTHYLIUM SALTS FOR TREATING TAUOPATHIES WISTA LAB LTD (SG) 2024-01-24 — — EP disclosed
US-20170088534-A1 3,6-DISUBSTITUTED XANTHYLIUM SALTS WISTA LABORATORIES LTD. (SG) 2017-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088534-A1 3,6-DISUBSTITUTED XANTHYLIUM SALTS MAPT, PSEN2, PSEN1 APP 5/4885MAPT 1/4885THRB 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback